Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
The American Journal of Human Genetics2003Vol. 72(5), pp. 1117–1130
Citations Over TimeTop 1% of 2003 papers
Antonis C. Antoniou, Paul D.P. Pharoah, Steven A. Narod, Harvey A. Risch, J.E. Eyfjörd, John L. Hopper, Niklas Loman, Håkan Olsson, Oskar T. Johannsson, Åke Borg, Barbara Pasini, Paolo Radice, Siranoush Manoukian, Diana Eccles, Nelson L.S. Tang, Edith Oláh, Hoda Anton‐Culver, Ellen Warner, Jan Lubiński, Jacek Gronwald, Bohdan Górski, Hrafn Tulinius, Steinunn Thorlacius, Hannaleena Eerola, Heli Nevanlinna, Kirsi Syrjäkoski, Olli Kallioniemi, Deborah J. Thompson, Chris Evans, Julian Peto, Fiona Lalloo, D. Gareth Evans, Douglas F. Easton
Related Papers
- → Limited significance of family history for presence of BRCA1 gene mutation in Polish breast and ovarian cancer cases(2012)30 cited
- → High Frequency of BRCA1 and BRCA2 Germline Mutations in Ashkenazi Jewish Ovarian Cancer Patients, Regardless of Family History(1997)79 cited
- → High Risk for Ovarian Cancer in a Prospective Series Is Restricted to BRCA1/2 Mutation Carriers(2008)18 cited
- → Ovarian cancer in women with known BRCA mutations: How much screening is too much?(2020)